Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-03 Sale | 2024-09-04 8:42 pm | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 68,506 | $26.12 | $1,789,190 | 125,037 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-09-01 Tax Withholding | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,738 | $26.74 | 125,037 (Direct) | View |
| 2024-07-15 Option Award | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 211 | $15.65 | 125,037 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 14,000 | $8.83 | 125,037 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 24,776 | $11.97 | 125,037 (Direct) | View |
| 2024-09-03 Exercise | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 29,730 | $11.1 | 125,037 (Direct) | View |
| 2024-09-01 Exercise | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 77,678 | $0 | 125,037 (Direct) | View |
| 2024-09-01 Option Award | 2024-09-04 8:42 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 43,062 | $0 | 125,037 (Direct) | View |
| 2024-04-08 Tax Withholding | 2024-04-08 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,353 | $17.9 | 79,058 (Direct) | View |
| 2024-04-08 Exercise | 2024-04-08 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 2,477 | $0 | 79,058 (Direct) | View |
| 2024-04-04 Option Award | 2024-04-08 5:19 pm | N/A 2034-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 48,631 | $0 | 79,058 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-03 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 880 | $19.7 | 19,985 (Direct) | View |
| 2024-04-01 Exercise | 2024-04-03 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,612 | $0 | 19,985 (Direct) | View |
| 2023-09-01 Tax Withholding | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,896 | $17.76 | 68,952 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 3,471 | $0 | 68,952 (Direct) | View |
| 2023-07-15 Option Award | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 292 | $12.35 | 68,952 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 45,113 | $0 | 68,952 (Direct) | View |
| 2023-04-10 Tax Withholding | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,353 | $10.71 | 19,984 (Direct) | View |
| 2023-04-10 Exercise | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 2,477 | $0 | 19,984 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 45,113 | $0 | 45,113 (Direct) | View |
| 2023-03-16 Tax Withholding | 2023-03-20 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 543 | $11.46 | 13,417 (Direct) | View |
| 2023-01-15 Option Award | 2023-03-20 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,844 | $9.56 | 13,417 (Direct) | View |
| 2023-03-16 Exercise | 2023-03-20 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 3,131 | $0 | 13,417 (Direct) | View |
| 2023-03-20 Tax Withholding | 2023-03-20 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,167 | $11.12 | 13,417 (Direct) | View |
| 2022-07-15 Option Award | 2022-09-06 4:12 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 360 | $9.56 | 80,514 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-06 4:12 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 995 | $0 | 80,514 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:12 pm | N/A 2032-08-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 69,368 | $0 | 80,514 (Direct) | View |
| 2022-09-02 Tax Withholding | 2022-09-06 4:12 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 563 | $11.44 | 80,514 (Direct) | View |
| 2022-04-07 Option Award | 2022-04-11 4:30 pm | N/A 2032-04-06 | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 69,368 | $0 | 69,368 (Direct) | View |
| 2022-03-21 Exercise | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 2,270 | $0 | 7,372 (Direct) | View |
| 2022-03-21 Tax Withholding | 2022-03-23 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,240 | $10.98 | 7,372 (Direct) | View |
| 2022-01-15 Option Award | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer | 1,546 | $9.63 | 9,324 (Direct) | View |
| 2021-07-15 Option Award | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer | 963 | $11.49 | 9,324 (Direct) | View |
| 2022-03-16 Tax Withholding | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer | 544 | $10.13 | 9,324 (Direct) | View |
| 2022-03-16 Exercise | 2022-03-18 4:39 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Chief Commercial Officer | 995 | $0 | 9,324 (Direct) | View |
| 2021-09-02 Option Award | 2021-09-07 5:16 pm | N/A 2031-09-01 | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross ARCALYST General Manager | 11,931 | $0 | 11,931 (Direct) | View |
Ownership | 2021-04-15 5:32 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Group VP & Rilonacept GM | 0 | $0 | 109,720 (Direct) | View |